Prothena Corp. Plc (PRTA)
9.02
-0.01
(-0.11%)
USD |
NASDAQ |
Feb 20, 16:00
9.02
0.00 (0.00%)
After-Hours: 20:00
Prothena EPS Diluted (Quarterly) : -0.401 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amarin Corp. Plc | -0.3701 |
| Jazz Pharmaceuticals Plc | 4.081 |
| Iterum Therapeutics Plc | -0.196 |
| GH Research Plc | -0.226 |
| Cosmo Pharmaceuticals NV | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -21.59M |
| Revenue (Quarterly) | 0.021M |
| Total Expenses (Quarterly) | 21.61M |
| Enterprise Value | 186.39M |
| Profit Margin (Quarterly) | -102.8K% |
| Earnings Yield | -50.27% |
| Normalized Earnings Yield | -45.94 |